{"id":3562,"date":"2017-12-08T17:06:41","date_gmt":"2017-12-08T22:06:41","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3562"},"modified":"2017-12-08T17:06:41","modified_gmt":"2017-12-08T22:06:41","slug":"ipo-weekly-recap-healthcare-deals-a-mixed-bag-in-mostly-positive-week","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-weekly-recap-healthcare-deals-a-mixed-bag-in-mostly-positive-week\/","title":{"rendered":"IPO Weekly Recap: Healthcare deals a mixed bag in mostly positive week"},"content":{"rendered":"<p><em><span style=\"font-weight: 400;\">Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the <\/span><b>TRUEST<\/b><span style=\"font-weight: 400;\"> picture of how an IPO is shaping up prior to its debut. We are on <\/span><b>your team. <\/b><span style=\"font-weight: 400;\">Additionally, we provide comprehensive research to outline short and long term risks of the new companies\u2026.. <\/span><b>A full-service firm! <\/b><\/em><\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">The IPO market returned from its post-Thanksgiving holiday slumber to five deals with a mixed bag of success. <\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/Screen-Shot-2017-12-08-at-4.59.41-PM.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-3563\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/Screen-Shot-2017-12-08-at-4.59.41-PM.png\" alt=\"IPORecap12.8.17\" width=\"1655\" height=\"225\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/Screen-Shot-2017-12-08-at-4.59.41-PM.png 1655w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/Screen-Shot-2017-12-08-at-4.59.41-PM-600x82.png 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/Screen-Shot-2017-12-08-at-4.59.41-PM-300x41.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/Screen-Shot-2017-12-08-at-4.59.41-PM-1024x139.png 1024w\" sizes=\"(max-width: 1655px) 100vw, 1655px\" \/><\/a><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/11\/DenaliTherapeutics.jpg\"><img decoding=\"async\" class=\"aligncenter size-full wp-image-3500\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/11\/DenaliTherapeutics.jpg\" alt=\"DenaliTherapeutics\" width=\"282\" height=\"69\" \/><\/a><\/p>\n<p><span style=\"font-weight: 400;\">The strongest deal of the week was <strong>Denali Therapeutics (DNLI)<\/strong> which followed suit with our channel checks. Denali upsized it\u2019s offering by 5.0mm shares (60%) and priced at the midpoint of the range, $18.00. DNLI opened with a first print of $21.55 for a gain of 19.7% at first trade.<\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/11\/OdonateTherapeutics.jpg\"><img decoding=\"async\" class=\"aligncenter size-full wp-image-3497\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/11\/OdonateTherapeutics.jpg\" alt=\"OdonateTherapeutics\" width=\"275\" height=\"63\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">The other Goldman Sachs underwritten biotech deal, <strong>Odonate Therapeutics (ODT)<\/strong>, did not pan out as well. ODT priced at the low-end of its range, $24.00, and opened $1.00 below the offering price. Odonate failed to trade above its offering price in its opening week. The other healthcare offering this week, <\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/QuanterixLogo.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-3514\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/QuanterixLogo.jpg\" alt=\"QuanterixLogo\" width=\"448\" height=\"80\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/QuanterixLogo.jpg 448w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/QuanterixLogo-300x54.jpg 300w\" sizes=\"(max-width: 448px) 100vw, 448px\" \/><\/a><\/p>\n<p><b>Quanterix Corp (QTRX)<\/b><span style=\"font-weight: 400;\">, upsized and priced at the midpoint of its $14.00-$16.00 range. QTRX opened at $16.25 and traded very well in its opening two days &#8212; printing over $18.00 on Friday for more than a 20% return.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-3517\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/LutherBurbank.jpg\" alt=\"LutherBurbank\" width=\"195\" height=\"123\" \/><\/p>\n<p><strong>Luther Burbank (LBC)\u00a0<\/strong>upsized its offering and priced near the bottom of the range, $10.75. The deal performed on par to how regional bank holding company offerings have done in 2017. LBC opened with a $1.00 premium and held steady throughout its opening session.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-3493\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/11\/CuroGroup.jpg\" alt=\"CuroGroup\" width=\"281\" height=\"64\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\"><strong>Curo Group Holdings (CURO)<\/strong> held steady in its opening week as a public company. CURO priced 6.67mm shares at the low-end of the range, $14.00, and opened with an $0.80 premium. CURO traded back near the opening price but remained above it in its first two sessions.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Looking ahead to this week&#8230;there are three deals on the schedule for the upcoming week. (Click on the image to see a preview of each deal).<\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/newmark-group-ipo-preview-nmrk\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-3554\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/NewmarkGroup.png\" alt=\"NewmarkGroup\" width=\"646\" height=\"194\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/casa-systems-ipo-preview-casa\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-3550\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/CasaSystems.jpg\" alt=\"Print\" width=\"420\" height=\"83\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/adial-pharmaceuticals-ipo-preview-dnli\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-3547\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/AdialPharma.jpg\" alt=\"AdialPharma\" width=\"368\" height=\"125\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/AdialPharma.jpg 368w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/AdialPharma-300x102.jpg 300w\" sizes=\"(max-width: 368px) 100vw, 368px\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-3562","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3562"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3562\/revisions"}],"predecessor-version":[{"id":3564,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3562\/revisions\/3564"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}